✦ LIBER ✦

EVALUATION OF OUTCOMES AND GENETIC PREDICTIVE FACTORS FOR PROGNOSIS AND TOXICITY IN HORMONE-REFRACTORY PROSTATE CANCER PATIENTS FOLLOWING COMBINATION THERAPY WITH DOCETAXEL, ESTRAMUSTINE, AND CARBOPLATIN

✍ Scribed by Narita, Shintaro; Tsuruta, Hiroshi; Saito, Mitsuru; Kumazawa, Teruaki; Horikawa, Yohei; Yuasa, Takeshi; Tsuchiya, Norihiko; Habuchi, Tomonori

Book ID: 123445290
Publisher: Lippincott Williams and Wilkins
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 181
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(09)60834-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome, clinical prognostic factors and

Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer

✍ Narita, Shintaro; Tsuchiya, Norihiko; Yuasa, Takeshi; Maita, Shinya; Obara, Taka 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 234 KB

A Phase II study of estramustine, doceta

A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony-stimulating factor support in patients with hormone-refractory prostate carcinoma : Cancer and Leukemia Group B 99813

✍ William K. Oh; Susan Halabi; W. Kevin Kelly; Cary Werner; Paul A. Godley; Nichol 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract ## BACKGROUND The authors determined the safety and efficacy of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor (G‐CSF) support in patients with hormone‐refractory prostate carcinoma. ## METHODS In the current multicenter, cooperative group study,

Combined external radiotherapy and hormo

Combined external radiotherapy and hormone therapy in patients with locally advanced prostate cancer: Predictive factors of genitourinary toxicity

✍ C. Ferrandis; J.A. March; J.M. Martínez; J. Hernández; N. Diez; V. Morillo; F. G 📂 Article 📅 2011 🏛 Elsevier ⚖ 310 KB